Telemedicine Marketing in the UAE: How Altibbi, Sehha and Okadoc Built Demand for Virtual Care

It is a Sunday night in JBR, and a Lebanese mother of two is putting her toddler down with a fever. She does not want to drive to a clinic. She opens an app — could be Altibbi, could be Sehha, could be Okadoc — types the symptoms in Arabic, sees three paediatricians available within fifteen minutes, picks the one with 4.9 stars and an Arabic-language video bio, pays AED 90 with Apple Pay, and is on a video call eight minutes later. By 9.40 p.m. she has a digital prescription routed to her preferred pharmacy in Marina Mall, and the toddler is asleep. That entire flow — from intent to resolution — is the telehealth product the UAE built. Marketing it is harder than it looks.

The UAE telehealth market in one paragraph

UAE telehealth is no longer experimental. Altibbi, headquartered in Dubai, serves more than twenty million users annually across ten Arab countries, with millions of consultations and a USD 44 million Series B in 2023 backed by Endeavor Catalyst, Middle East Venture Partners, and the UAE Ministry of Health. Sehha, owned by Daman, leverages the largest insurance subscriber base in Abu Dhabi to push virtual consults that bill against existing plans. Okadoc, with USD 22.3 million raised in total, is the strongest appointment-booking platform with deep integrations into UAE hospital networks. The market also includes Vezeeta out of Egypt, regional EMR-linked tools, and insurer-built platforms like Allianz Care's LiveDoc Video Consultation launched with Orient Insurance and NextCare in 2022.

What looks like a crowded market from the outside is actually three different markets — asynchronous symptom-led consultations (Altibbi's strength), insurance-funded virtual visits (Sehha's strength), and synchronous appointment booking with named providers (Okadoc's strength). The platforms that confused themselves about which market they were in burned cash. The platforms that picked one and built deeply have raised follow-on rounds.

The DHA Telehealth Standards — what every marketer needs to know

The Dubai Health Authority issued the Standards for Telehealth Services Version 4 on 26 September 2025, with an effective date of 26 November 2025. The standards govern licensing of telehealth facilities, the qualifications of practitioners, data residency, and the technical environment. Health data must be stored on servers located within the UAE, or on a cloud service provider holding the relevant certification. Facilities require ISO 27001-equivalent cybersecurity. The DHA exam blueprint for licensure now weights questions on telemedicine operations, digital ethics, and data sovereignty significantly. Only authorised facilities may provide remote consultation, diagnosis, treatment, prescription issuance and patient monitoring.

The marketing implication is not optional. Every paid acquisition campaign must run through a licensed facility, every doctor profile on the platform must show a valid DHA, DoH, or MOHAP licence number, and every consultation flow must keep patient data inside UAE-resident infrastructure. Platforms that cut corners on data residency to use cheaper US-based cloud regions are one regulatory inspection away from a public licence suspension. The marketing function has to be in the room when the data architecture is decided. We help digital health platforms navigate that overlap as part of our digital marketing engagements.

Arabic symptom-search is the demand engine

Altibbi's twenty million annual users were not built on paid acquisition. They were built on Arabic-language symptom and condition content that ranks for the queries an Arabic-speaking patient actually types — "ألم في الجانب الأيمن من البطن" (pain in the right side of the abdomen), "حبوب الكورتيزون أعراضها" (cortisone pill side effects), "تشخيص حساسية الجلد" (skin allergy diagnosis). The platform built thousands of pages, each with a doctor-author byline, an answer that addresses the question directly, related conditions, and an instant booking widget at the natural decision point in the page. That is an organic growth engine that compounds over years.

The platforms that try to skip this stage and run pure paid acquisition for telemedicine app installs end up with high install costs and low retention, because the user who installed from a Meta ad has no urgent reason to open the app on a Sunday night. The user who landed on a symptom page at 9.30 p.m. and saw "book a paediatrician now" has every reason to convert. We have rebuilt blog and condition-page architectures for digital health clients where organic search traffic moved from a few thousand monthly sessions to six figures within nine months — the work is hard but the curve is real.

Doctor-creators and the new acquisition channel

The single most underused growth lever in UAE telehealth is the doctor-creator. A dermatologist with 250,000 Instagram followers who posts in Khaleeji-friendly Arabic about acne, skincare, and laser treatments, with a booking link in her bio that routes through Okadoc or Sehha, is acquiring patients at a fraction of the cost of paid social. A paediatrician on TikTok who answers parent questions in two-minute videos is building category demand the platforms cannot buy directly. The MOHAP rules require the doctor-creator to obtain advertising approval before promoting health products on social, and the UAE Media Council's 2026 Advertiser Permit requirement adds another compliance layer. Done correctly, however, the doctor-creator partnership is the most efficient acquisition channel in the category.

The structure that works is a revenue-share or per-consult-attribution agreement, a content production budget that the platform contributes (lighting, editing, scripting), and clear creative guardrails so the doctor stays inside her clinical scope and inside MOHAP rules. The platforms that try to onboard hundreds of casual doctor-influencers without structure usually generate compliance risk that outweighs the acquisition benefit. The platforms that pick ten or twenty serious doctor-creators and invest in them properly have a moat. Our work on content creation for healthcare brands is largely about building this kind of repeatable structure.

Insurance integration changes the economics

A virtual consult that costs the patient AED 90 out of pocket is a different product from a virtual consult that the patient does not pay for at all because the insurer is the payer. Sehha's structural advantage is that Daman covers a meaningful portion of its consults under existing plans, which removes the price friction at the moment of booking. The Allianz Care, Orient Insurance, and NextCare partnership for LiveDoc Video Consultation is built on the same logic. For new entrant telehealth platforms, the question is not whether to pursue insurance integration but how — and the answer usually involves several quarters of contracting work with each major insurer before the first consult is reimbursed.

The marketing implication is that the platform that can show "covered by your insurance" at the point of booking converts dramatically better than the platform that cannot. Marketing teams should treat insurance integration milestones as launch moments — when Sehha announces coverage with a new payer, the announcement itself is a marketing campaign because it materially changes the customer's perceived price.

Positioning against incumbents — the new entrant playbook

If you are launching a new UAE telehealth platform in 2026, head-on competition with Altibbi, Sehha, and Okadoc on general consults is a slow way to lose. The new entrants that have done well have specialised — chronic disease management for diabetes and hypertension (a population in the GCC large enough to support a focused platform), women's health (where the cultural friction of seeing a male doctor in person makes the virtual modality particularly suitable), paediatrics (where parental urgency is highest), and mental health (where the privacy of the virtual modality breaks a real stigma barrier).

The other route that works is B2B — building the telehealth platform that an insurer or hospital licenses as the white-label virtual care layer, rather than trying to build a consumer brand from scratch. The new entrants that pursue this route trade upside for capital efficiency, and several have built reasonable businesses. The route that does not work is generic mass-market positioning with paid-only acquisition.

What this looks like in practice

A specialist UAE telehealth platform focused on women's health rebuilt its marketing in the second half of 2024 around three principles — Arabic symptom-search content as the primary demand engine, a network of eight named female doctor-creators with structured production support and revenue share, and a partnership with two regional insurers covering virtual gynaecology consults. By the third quarter of 2025, the platform had moved from roughly 3,000 monthly active consults to 18,000, customer acquisition cost had dropped from AED 280 to AED 65, and retention at the 60-day mark had improved from 22 percent to 51 percent. The win was not a cleverer ad. It was the structure of the demand engine.

The hardest part was the data architecture. Migrating consultation data to UAE-resident cloud infrastructure took longer than expected, and the marketing team had to delay one regional launch by a quarter while the compliance work caught up. The CFO eventually agreed it was the right call — a public DHA citation would have erased a year of brand building.

Final paragraph + CTA

UAE telehealth marketing in 2026 rewards platforms that build organic demand engines in Arabic, partner with doctor-creators on structured terms, integrate seriously with insurers, and respect the DHA, DoH, and MOHAP regulations as a creative constraint rather than a checkbox. The wider GCC healthcare picture is mapped in healthcare marketing in the GCC, and the broker-side insurance lens sits alongside it in health insurance broker marketing. If you are scaling a digital health platform in the UAE and want a marketing partner with senior strategist depth, talk to Santa Media.

Frequently Asked Questions

Do I need a separate licence to operate a telehealth platform in the UAE?

Yes. The DHA Standards for Telehealth Services Version 4 require platform-level licensing for any facility offering remote consultation, diagnosis, treatment, prescription issuance, or patient monitoring in Dubai. Abu Dhabi's DoH and the federal MOHAP have parallel requirements. Operating an unlicensed telehealth service is not a grey area in the UAE.

How does Altibbi acquire patients without spending heavily on paid media?

Altibbi's organic growth engine is built on Arabic-language symptom and condition content. Thousands of pages, each authored by a credentialled doctor, rank for the questions Arabic-speaking patients actually type. The booking widget is embedded at the decision point within the article, so the platform converts intent at the moment it is highest.

Is doctor-creator partnership a real acquisition channel in 2026?

Yes, when structured. A revenue-share or per-consult attribution model with a small number of serious doctor-creators, supported by content production budget and clear MOHAP compliance guardrails, is the most efficient acquisition channel in the category. Bulk influencer programmes without structure tend to create more compliance risk than acquisition value.

Can a UAE telehealth platform host its data outside the UAE?

No. The DHA Telehealth Standards require health data to be stored on servers located within the UAE, or on a cloud service provider holding the relevant certification for UAE health data. Platforms using non-compliant US or EU cloud regions are at material risk of licence suspension.

Should a new entrant compete head-on with Altibbi and Sehha?

Rarely. The new entrants that have built sustainable businesses have specialised by condition or population — women's health, paediatrics, chronic disease management, mental health — or operated as white-label B2B platforms for insurers and hospitals. Generic mass-market positioning without a specialised hook is the slowest path to product-market fit.